Apollo Endosurgery Inc
F:HQ8F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Navkar Corporation Ltd
NSE:NAVKARCORP
|
IN |
Apollo Endosurgery Inc
Free Cash Flow
Apollo Endosurgery Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Apollo Endosurgery Inc
F:HQ8F
|
Free Cash Flow
-$34m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-15%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$3.7B
|
CAGR 3-Years
45%
|
CAGR 5-Years
22%
|
CAGR 10-Years
23%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Free Cash Flow
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$4.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$2.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Apollo Endosurgery Inc
Glance View
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
See Also
What is Apollo Endosurgery Inc's Free Cash Flow?
Free Cash Flow
-34m
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Free Cash Flow amounts to -34m USD.
What is Apollo Endosurgery Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-15%
Over the last year, the Free Cash Flow growth was -114%. The average annual Free Cash Flow growth rates for Apollo Endosurgery Inc have been -9% over the past three years , -17% over the past five years , and -15% over the past ten years .
